Functionally, either deletion of MUC1 under hypoxic conditions or pharmacologic inhibition of MUC1-C with the cell-penetrant inhibitor GO-203 increased mitochondrial reactive oxygen species in circulating tumor cells and reduced the contribution of hypoxia-experienced cells to lung metastasis in vivo (14). The gene discussed is MUC1; the disease is neoplasm.